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Diagnosing Patent Foramen Ovale
Too Little or Too Much?*
Itzhak Kronzon, MD,† Carlos E. Ruiz, MD, PHD‡
New York, New YorkIt is estimated that 25% to 30% of the world’s
population, or 1.7 to 2.0 billion individuals, have
patent foramen ovale (PFO). The vast majority of
these people will have no problem associated with
this condition. Very rarely, the pathogenesis of
stroke or peripheral arterial embolization includes
paradoxical embolization related to a thrombus
formed in the systemic venous system or the right
See page 343
atrium and its crossing the interatrial septum via a
PFO (1). In recent years, it has been suggested that
patients with cryptogenic strokes or transient isch-
emic attacks (TIA) have a higher prevalence of
PFO (2,3). Furthermore, the presence of PFO has
been implicated in many other pathological entities,
such as migraine headaches, orthodeoxia-platypnea
syndrome, decompression illness, refractory hypox-
emia, and sleep apnea syndrome (4,5).
The ingenuity and creativity of physicians,
inventors, and the medical device industry have
led to the design of systems capable of closing
PFOs using a percutaneous transcatheter ap-
proach. Although there is still no clear-cut,
evidence-based recommendation for the use of
these closure devices for secondary prevention in
individuals with stroke or TIA who also have
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Medtronic-CoreValve.PFO, such closure is frequently performed by
many practitioners in an attempt to prevent the
catastrophe associated with a second embolic
event (6,7). Although the best therapeutic ap-
proach is still debated, it is generally accepted
that accurate diagnosis of PFO is a sine qua non
in patients with embolic stroke or TIA.
Our diagnostic armamentarium includes cardiac
catheterization, which can show the PFO by the
path of the venous catheter from the right to the left
atrium, and Doppler echocardiography, which can
show the blood flow across the PFO. During
echocardiography, intravenous injection of agitated
saline (bubble injection) is used to document the
transit of these bubbles from right to left across
the PFO. Although transthoracic echocardiogra-
phy can be diagnostic, its sensitivity is relatively
low. Higher-resolution echocardiographic images,
such as those obtained by transesophageal echocar-
diography (TEE) or intracardiac echocardiography
(ICE), are possible using high-frequency transduc-
ers brought to closer proximity to the heart, thereby
providing higher sensitivity and specificity for PFO
detection. Finally, transcranial Doppler (TCD)
studies can, after intravenous agitated saline injec-
tion, show the appearance of the bubbles in the
middle cerebral artery, thereby suggesting the diag-
nosis of right-to-left shunt (RLS) via a PFO.
The RLS across the PFO depends on the pres-
sure gradient between the right and left atria.
Normally, the left atrial pressure is slightly higher
than the right atrial pressure throughout the cardiac
cycle, and thus a RLS is not possible. Interestingly,
in many such cases, the PFO is not hermetically
sealed, and a small left-to-right shunt is frequently
detected by color flow Doppler.
To produce a RLS, the right atrial pressure must
exceed the left atrial pressure. This occurs in con-
ditions such as pulmonary embolism, right ventric-
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350lar failure, and tricuspid insufficiency, or during
he release stage of the Valsalva maneuver. The
training phase of the Valsalva maneuver raises the
ntrathoracic pressure, and thus both atrial pres-
ures. It also compresses the intrathoracic pulmo-
ary veins and the intrathoracic portion of the venae
avae (8,9). The extrathoracic portions of the venae
avae become engorged, as can be seen when
bserving a patient who performs the straining.
ith the release phase of the maneuver, the in-
reased systemic venous return precedes the pulmo-
ary venous return, thus creating a right-to-left
trial pressure gradient.
When clinically indicated, most practitioners at-
empt to visualize PFOs by echocardiography fol-
owing the intravenous injection of agitated saline
s the patient performs the Valsalva maneuver. The
mmediate appearance of 3 or more bubbles in the
eft atrium across the atrial septum is considered
iagnostic. Unfortunately, even with the use of
igh-resolution TEE or ICE, this procedure may
ail to diagnose PFO (10). This failure to diagnose
ay be related to an insufficient increase in the
ight atrial pressure above the left atrial pressure
ecessary to drive bubbles across the PFO. This may
e the case especially in patients who have high left
trial pressure. The tomographic nature of the images
btained echocardiographically may be another reason
hy bubbles could be missed.
The method suggested by Van et al. (11) in this
ssue of iJACC may overcome these shortfalls and
ay be more sensitive for the detection of PFO.
hese investigators studied patients with known
FO before and after transcatheter device closure.
hey showed that blowing into a manometer at a
ressure of 40 mm Hg resulted in higher right atrial
ressure as compared with that attained with the
alsalva maneuver. This was associated with signif-
cantly more bubbles detected in the middle cerebral
rtery by TCD. Furthermore, with the use of the
anometer, they detected bubbles by TCD in cases
n which ICE results were negative. This technique
f combining blowing into a manometer with use of
CD may be not only more sensitive, but also more
ost effective. It is almost completely noninvasivewald, 1877:134. echocardiographicgitated saline). Unlike TEE, there is no need for
sophageal intubation, and unlike ICE, there is no
eed to use expensive, disposable invasive imaging
atheters.
The Valsalva maneuver is not quantitative, and
he degree of straining is variable. Patients stud-
ed using TEE are frequently sedated and there-
ore are less cooperative; they do not follow
rders and often do not perform the maneuver
ffectively. The new technique is easily per-
ormed, and the patient can readily adjust the
ntensity of exhalation to obtain the target pres-
ure indicated on the manometer.
The exact specificity of the technique suggested
y Van et al. (11) is unknown. All of their studies
ere performed in patients with known PFOs, and
here was no control group to evaluate the tech-
ique in patients without PFOs. It is therefore
nclear whether transient nonphysiologic eleva-
ion of intrathoracic pressure may be by itself
esponsible for the appearance of the bubbles in
he left heart by mechanisms other than inter-
trial shunting, such as changes in gas solubility
n the blood or opening of new arteriovenous
hannels in the lungs.
The gold standard for detecting the presence of
FO has traditionally been the demonstration of a
robe-patent PFO on a surgical or a pathological
pecimen. Obviously, 10-m bubbles can travel
rom left to right across a microscopic hole or a pore
n the atrial septum or the device that closed it.
uch defects may not be visualized by any macro-
copic observation.
Van et al. (11) should be commended for their
ttempt to produce a standardized, possibly more
ensitive test to define the RLS across a PFO.
owever, the clinical implications and the added
alue of shunt detection only by TCD and not by
EE or ICE are yet to be defined and will require
urther clarification.
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